Related Experiment Video
Updated: Apr 17, 2026
08:38
Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
Published on: September 1, 2011
76.3K
Dopaminergic medication alters auditory distractor processing in Parkinson's disease
Dejan Georgiev1, Marjan Jahanshahi2, Jurij Dreo3
1Department of Neurology, University Medical Centre, Zaloška cesta 2, 1000 Ljubljana, Slovenia; Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, University College London, 33 Queen Square, London WC1N 3BG, United Kingdom.
Acta Psychologica
|February 21, 2015
Summary
Dopamine medication significantly impacts auditory attention in Parkinson's disease (PD) patients, specifically affecting how they process distracting sounds. This finding suggests medication influences cognitive functions beyond motor control.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Neurology
Background:
- Parkinson's disease (PD) often presents with cognitive impairments, including attention deficits, even early in the disease course.
- The precise effects of dopaminergic medication on cognitive functions in PD remain incompletely understood.
- Attentional processing is crucial for daily functioning and may be modulated by dopaminergic therapy.
Purpose of the Study:
- To investigate the impact of dopaminergic medication on visual and auditory attentional processing in Parkinson's disease patients.
- To compare attentional processing between Parkinson's disease patients (on and off medication) and healthy controls.
- To utilize electroencephalography (EEG) to measure neural correlates of attentional processing.
Main Methods:
- A cohort of 14 Parkinson's disease patients and 13 matched healthy controls underwent an auditory and visual oddball task.
- EEG recordings were obtained during task performance for all participants.
- Parkinson's disease patients completed the task in both medicated (on-medication) and unmedicated (off-medication) states.
Main Results:
- No significant differences in attentional processing were observed between Parkinson's disease patients and healthy controls.
- A significant increase in P3 amplitude was found when patients were on medication compared to off-medication, specifically for auditory distractor stimuli.
- This medication-related effect on P3 amplitude was not observed for visual stimuli or other stimulus types.
Conclusions:
- Dopaminergic medication significantly influences the processing of auditory distractors in Parkinson's disease patients.
- The observed increase in P3 amplitude suggests potential alterations in attentional resource allocation, cognitive inhibition, or stimulus discrimination related to auditory distractors.
- Further research is necessary to elucidate the specific mechanisms underlying these medication effects on auditory attentional processing in PD.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:15Parkinson's Disease: Overview
2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
01:29Drugs Affecting Neurotransmitter Synthesis
2.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.6K
01:30Attention-Deficit/Hyperactivity Disorder
1.4K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
01:37Neural Regulation
45.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.2K